Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
- Disease/Condition
- Infection
- Drug/Device/Intervention
- Technical assistance or team-based coaching
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Trustees of Dartmouth College
- Location
- Iowa City,Hanover, United States of America
- Phase
- N/A
- Start date
- Jul 01, 2021
- End date
- Jun 30, 2026
- Enrollment
- 6000 participants
ESKAPE Transmission Events
Surgical site infections (SSIs) are associated with increased patient morbidity, mortality,
 and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter,
 Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have
 increased capacity to acquire resistance and virulence traits. The investigators have proven
 that a multifaceted program involving improved basic perioperative preventive measures can
 generate substantial reductions in S. aureus transmission and significant reductions in SSIs
 (88% reduction as compared to usual care). In this study, the investigators aim to examine
 the relative effectiveness of each component of this program in controlling ESKAPE
 transmission and reducing SSIs and to identify an optimal implementation strategy for
 national dissemination. Randomization occurs at the site level, and sites adopt preventative
 programs. This work will improve perioperative patient safety for the 51 million patients who
 undergo surgery each year.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04600973
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04600973 through Pure Global AI's free database. This phase not specified trial is sponsored by Trustees of Dartmouth College and is currently Not yet recruiting. The study focuses on Infection. Target enrollment is 6000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.